The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response-Reference-Cited by-同舟云学术

The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response

Published:2017-06-30 Issue:9 Volume:102 Page:3452-3460
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Ooi Teik Chye,Krysa Jacqueline A,Chaker Seham,Abujrad Hussein,Mayne Janice,Henry Kathy,Cousins Marion,Raymond Angela,Favreau Colette,Taljaard Monica,Chrétien Michel,Mbikay Majambu,Proctor Spencer D,Vine Donna F

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/102/9/3452/19703454/jc.2017-00684.pdf

Reference40 articles.

1. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Proc Natl Acad Sci USA,2003

2. 60 YEARS OF POMC: From the prohormone theory to pro-opiomelanocortin and to proprotein convertases (PCSK1 to PCSK9);J Mol Endocrinol,2016

3. Proprotein convertases subtilisin/kexin type 9, an enzyme turned escort protein: hepatic and extra hepatic functions;J Diabetes,2013

4. Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation;J Biol Chem,2007

5. Evolocumab and clinical outcomes in patients with cardiovascular disease;FOURIER Steering Committee and Investigators;N Engl J Med,2017

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Predictive Utility of Circulating PCSK9 Levels on Diabetic Retinopathy Stage;Current Eye Research;2024-07-31

2. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

3. PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes;Cardiovascular Drugs and Therapy;2024-06-22

4. The role of natural products as PCSK9 modulators: A review;Phytotherapy Research;2024-06-20

5. PCSK9 in extrahepatic tissues: What can we expect from its inhibition?;European Atherosclerosis Journal;2023-08-31